- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUL: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUL.2: 7 residues within 4Å:- Chain A: N.65, D.66, H.69, W.356, I.388
- Chain B: N.382, F.385
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.65, A:D.66
NAG-NAG-BMA-FUL.14: 7 residues within 4Å:- Chain C: N.65, D.66, H.69, W.356, I.388
- Chain D: N.382, F.385
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.65, C:D.66
- 2 x NAG- NAG- BMA- MAN- BMA- MAN: beta-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-BMA-MAN.3: 20 residues within 4Å:- Chain A: N.119
- Chain B: T.14, G.15, F.16, L.240, W.280, T.295, F.296, K.297, S.309, Q.310, I.311, N.312, R.313, Q.314, V.315, Y.372, G.373, T.374, G.375
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.312, B:N.312, B:R.313, B:I.311, B:R.313, B:R.313, B:T.374
NAG-NAG-BMA-MAN-BMA-MAN.15: 20 residues within 4Å:- Chain C: N.119
- Chain D: T.14, G.15, F.16, L.240, W.280, T.295, F.296, K.297, S.309, Q.310, I.311, N.312, R.313, Q.314, V.315, Y.372, G.373, T.374, G.375
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.312, D:N.312, D:R.313, D:I.311, D:R.313, D:R.313, D:T.374
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUC.6: 7 residues within 4Å:- Chain B: N.65, D.66, H.69, W.356, I.388
- Chain C: N.382, F.385
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.65, B:D.66
NAG-NAG-BMA-FUC.18: 7 residues within 4Å:- Chain A: N.382, F.385
- Chain D: N.65, D.66, H.69, W.356, I.388
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.65, D:D.66
- 2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.7: 20 residues within 4Å:- Chain B: N.119
- Chain C: T.14, G.15, F.16, L.240, W.280, T.295, F.296, K.297, S.309, Q.310, I.311, N.312, R.313, Q.314, V.315, Y.372, G.373, T.374, G.375
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.312, C:N.312, C:R.313, C:Q.310, C:Q.310, C:R.313, C:R.313, C:R.313, C:T.374
NAG-NAG-BMA-MAN-MAN-MAN.19: 20 residues within 4Å:- Chain A: T.14, G.15, F.16, L.240, W.280, T.295, F.296, K.297, S.309, Q.310, I.311, N.312, R.313, Q.314, V.315, Y.372, G.373, T.374, G.375
- Chain D: N.119
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.312, A:N.312, A:R.313, A:Q.310, A:Q.310, A:R.313, A:R.313, A:R.313, A:T.374
- 4 x CA: CALCIUM ION(Non-covalent)
CA.9: 6 residues within 4Å:- Chain A: D.212, G.216, D.243, G.264, T.265, Q.266
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:D.212, A:G.216, A:G.264, A:Q.266
CA.11: 6 residues within 4Å:- Chain B: D.212, G.216, D.243, G.264, T.265, Q.266
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:D.212, B:G.216, B:G.264, B:Q.266
CA.21: 6 residues within 4Å:- Chain C: D.212, G.216, D.243, G.264, T.265, Q.266
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:D.212, C:G.216, C:G.264, C:Q.266
CA.23: 6 residues within 4Å:- Chain D: D.212, G.216, D.243, G.264, T.265, Q.266
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:D.212, D:G.216, D:G.264, D:Q.266
- 4 x ST6: 4-(ACETYLAMINO)-3-[(AMINOACETYL)AMINO]BENZOIC ACID(Non-covalent)
ST6.10: 12 residues within 4Å:- Chain A: R.37, E.38, D.70, R.71, W.97, R.143, E.146, E.195, E.196, R.211, R.290, Y.325
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:D.70, A:W.97
- Hydrogen bonds: A:D.70, A:R.71, A:E.195, A:R.211, A:Y.325
- Salt bridges: A:R.37, A:R.290
ST6.12: 12 residues within 4Å:- Chain B: R.37, E.38, D.70, R.71, W.97, R.143, E.146, E.195, E.196, R.211, R.290, Y.325
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:D.70, B:W.97
- Hydrogen bonds: B:D.70, B:R.71, B:E.195, B:R.211, B:Y.325
- Salt bridges: B:R.37, B:R.290
ST6.22: 12 residues within 4Å:- Chain C: R.37, E.38, D.70, R.71, W.97, R.143, E.146, E.195, E.196, R.211, R.290, Y.325
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:D.70, C:W.97
- Hydrogen bonds: C:D.70, C:D.70, C:R.71, C:E.195, C:R.211, C:Y.325
- Salt bridges: C:R.37, C:R.290
ST6.24: 12 residues within 4Å:- Chain D: R.37, E.38, D.70, R.71, W.97, R.143, E.146, E.195, E.196, R.211, R.290, Y.325
10 PLIP interactions:10 interactions with chain D- Hydrophobic interactions: D:D.70, D:W.97
- Hydrogen bonds: D:D.70, D:D.70, D:R.71, D:E.195, D:R.211, D:Y.325
- Salt bridges: D:R.37, D:R.290
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Singh, S. et al., Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. J.Med.Chem. (1995)
- Release Date
- 1996-08-17
- Peptides
- INFLUENZA A SUBTYPE N2 NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUL: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- BMA- MAN: beta-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x ST6: 4-(ACETYLAMINO)-3-[(AMINOACETYL)AMINO]BENZOIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Singh, S. et al., Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. J.Med.Chem. (1995)
- Release Date
- 1996-08-17
- Peptides
- INFLUENZA A SUBTYPE N2 NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B